Artwork

Indhold leveret af BackTable LLC. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af BackTable LLC eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Ep. 483 Endovascular Innovations: The Ellipsys Story with Dr. Jeff Hull

58:43
 
Del
 

Manage episode 442255281 series 2658136
Indhold leveret af BackTable LLC. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af BackTable LLC eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Surgical arteriovenous fistula (AVF) creation has been a mainstay of dialysis care for multiple decades. What does it take to break into such an established space with a new endovascular medical device? In this episode of the BackTable Podcast, Dr. Jeffrey Hull discusses the challenging journey of developing the Ellipsys system for endovascular AVF creation.

---

CHECK OUT OUR SPONSOR

Medtronic ClosureFast

https://www.medtronic.com/closurefast6f

---

SYNPOSIS

We trace Dr. Hull’s path from the device's initial conception in 2006, through the first-in-human cases in 2013, to regulatory approval and acquisition by Medtronic in 2020. Dr. Hull highlights the roles of key business mentors, the importance of multidisciplinary collaboration with vascular surgery and nephrology, and the impact of investment. He also shares valuable insights on the benefits of having competitors and selecting a well-thought-out exit strategy. Additionally, we explore deep vein arterialization (DVA) as another application of endovascular AVF creation in the context of peripheral arterial disease.

---

TIMESTAMPS

00:00 - Introduction

03:05 - The Birth of the Percutaneous AV Fistula Creation

15:04 - First-in-Human Cases

17:58 - Navigating the Startup Journey

21:52 - Identifying Mentors and Investors

27:33 - Competition and Criticism

36:43 - Regulatory Hurdles

44:45 - Acquisition by Medtronic

49:14 - Deep Vein Arterialization for Peripheral Arterial Disease

54:40 - Final Thoughts and Advice

---

RESOURCES

Avenu Medical:

https://avenumedical.com/

Gracz KC et al. Proximal forearm fistula for maintenance hemodialysis (1977):

https://pubmed.ncbi.nlm.nih.gov/839655/

Hull JE et al. The Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula Creation for Hemodialysis Access (2018):

https://pubmed.ncbi.nlm.nih.gov/29275056/

Endovascular Today- Update on Percutaneous AV Fistula Creation (2015):

https://evtoday.com/articles/2015-june/update-on-percutaneous-av-fistula-creation

Mallios A, Jennings WC. Percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System-the state of the art (2020):

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353338/

  continue reading

508 episoder

Artwork
iconDel
 
Manage episode 442255281 series 2658136
Indhold leveret af BackTable LLC. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af BackTable LLC eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Surgical arteriovenous fistula (AVF) creation has been a mainstay of dialysis care for multiple decades. What does it take to break into such an established space with a new endovascular medical device? In this episode of the BackTable Podcast, Dr. Jeffrey Hull discusses the challenging journey of developing the Ellipsys system for endovascular AVF creation.

---

CHECK OUT OUR SPONSOR

Medtronic ClosureFast

https://www.medtronic.com/closurefast6f

---

SYNPOSIS

We trace Dr. Hull’s path from the device's initial conception in 2006, through the first-in-human cases in 2013, to regulatory approval and acquisition by Medtronic in 2020. Dr. Hull highlights the roles of key business mentors, the importance of multidisciplinary collaboration with vascular surgery and nephrology, and the impact of investment. He also shares valuable insights on the benefits of having competitors and selecting a well-thought-out exit strategy. Additionally, we explore deep vein arterialization (DVA) as another application of endovascular AVF creation in the context of peripheral arterial disease.

---

TIMESTAMPS

00:00 - Introduction

03:05 - The Birth of the Percutaneous AV Fistula Creation

15:04 - First-in-Human Cases

17:58 - Navigating the Startup Journey

21:52 - Identifying Mentors and Investors

27:33 - Competition and Criticism

36:43 - Regulatory Hurdles

44:45 - Acquisition by Medtronic

49:14 - Deep Vein Arterialization for Peripheral Arterial Disease

54:40 - Final Thoughts and Advice

---

RESOURCES

Avenu Medical:

https://avenumedical.com/

Gracz KC et al. Proximal forearm fistula for maintenance hemodialysis (1977):

https://pubmed.ncbi.nlm.nih.gov/839655/

Hull JE et al. The Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula Creation for Hemodialysis Access (2018):

https://pubmed.ncbi.nlm.nih.gov/29275056/

Endovascular Today- Update on Percutaneous AV Fistula Creation (2015):

https://evtoday.com/articles/2015-june/update-on-percutaneous-av-fistula-creation

Mallios A, Jennings WC. Percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System-the state of the art (2020):

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353338/

  continue reading

508 episoder

Todos los episodios

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning